122 related articles for article (PubMed ID: 7991990)
1. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
Chariyalertsak S; Sugano K; Ohkura H; Mori Y
Tumour Biol; 1994; 15(5):294-303. PubMed ID: 7991990
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
3. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
4. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
[TBL] [Abstract][Full Text] [Related]
5. Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.
Takehana T; Kunitomo K; Kono K; Kitahara F; Iizuka H; Matsumoto Y; Fujino MA; Ooi A
Int J Cancer; 2002 Apr; 98(6):833-7. PubMed ID: 11948459
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein.
Rebischung C; Barnoud R; Stéfani L; Faucheron JL; Mousseau M
Gastric Cancer; 2005; 8(4):249-52. PubMed ID: 16328600
[TBL] [Abstract][Full Text] [Related]
8. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
[TBL] [Abstract][Full Text] [Related]
9. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer.
Isola JJ; Holli K; Oksa H; Teramoto Y; Kallioniemi OP
Cancer; 1994 Feb; 73(3):652-8. PubMed ID: 7905363
[TBL] [Abstract][Full Text] [Related]
10. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Ajisaka H; Fushida S; Yonemura Y; Miwa K
Hepatogastroenterology; 2001; 48(42):1788-92. PubMed ID: 11813625
[TBL] [Abstract][Full Text] [Related]
12. Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer.
Yonemura Y; Ninomiya I; Ohoyama S; Fushida S; Kimura H; Tsugawa K; Kamata T; Yamaguchi A; Miyazaki I; Endou Y
Oncology; 1992; 49(5):363-7. PubMed ID: 1356259
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer.
Kanai T; Konno H; Maruyama K; Baba M; Tanaka T; Maruo Y; Nishino N; Nakamura S; Baba S; Sugimura H
Eur Surg Res; 1997; 29(1):35-41. PubMed ID: 9013104
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
Wei Z; Wu Y; Zhai Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma].
Gong Z; Luo E; Lu Q
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):299-301. PubMed ID: 9387327
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.
Dursun A; Poyraz A; Celik B; Akyol G
Pathol Oncol Res; 1999; 5(2):104-6. PubMed ID: 10393360
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
19. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
